Status:
UNKNOWN
Telemonitoring and Connected Care Applied to Multiple Sclerose
Lead Sponsor:
Isala
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators designed a new care concept based on a multi-modal version of the MSmonitor program, the 'MSmonitor-Plus and Video Calling Care' (MPVC). MPVC combines the self-management and educati...
Detailed Description
Multiple sclerosis (MS) is the most common neurological disorder (1:500-1000) in young adults. It has a profound impact on all aspects of human functioning. The clinical picture is comprehensive fati...
Eligibility Criteria
Inclusion
- The participant is an MS patient who is being treated within the Isala. Is 18 years of age or older Has digital skills
- The caregiver is the caregiver of an MS patient Is older than 18 years
Exclusion
- The patient does not master the Dutch language. The patient has insufficient computer skills. Disabled adults are excluded from the study.
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT05242731
Start Date
April 29 2021
End Date
December 31 2025
Last Update
October 10 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Nederland, Netherlands, 9713AV
2
University of Maastricht
Maastricht, Nederland, Netherlands, 6200MD
3
MS4research Institute
Nijmegen, Nederland, Netherlands, 6522KJ
4
Isala
Zwolle, Nederland, Netherlands, 7943KA